Skip to main content

Advertisement

Table 2 Clinical, pathological and genomic features vs recurrent disease (N = 37)

From: Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

  N% Recurrent disease (N = 13) (35%) N% Non-recurrent disease (N = 24) (64.9%) P value
Age(mean) 64.0 years 61.8 years p = 0.612 (t-test)
Tumor grade
G1 + G2 8.(62) 14 (58)  
G3 5 (38) 10 (42) p = 0.849 (chi-2)
FIGO stage    
IA-IC 8 (61) 23 (96)  
II 5 (42) 1 (4) p = 0.007 (chi-2)
Staging
adequate 1 (8) 6 (25)  
not adequate 12 (92) 18 (75) p = 0.199 (chi-2)
LOH detected
at19q (51-56Mbp) 8 (62) 3 (12)  
No. LOH at 19q 5 (38) 21 (88) p = 0.002 (chi 2)
(51-56Mbp) detected    
TP53 status
positive 8 (62) 4 (17)  
negative 5 (38) 20 (83) p = 0.005 (chi-2)